Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Hodge Website

Deborah L Hodge, Ph.D.

Selected Publications

1)  Subleski JJ, Hall VL, Wolfe TB, Scarzello AJ, Weiss JM, Chan T, Hodge DL, Back TC, Ortaldo JR, Wiltrout RH.
TCR-dependent and -independent activation underlie liver-specific regulation of NKT cells.
J. Immunol. 186: 838-47, 2011.
[Journal]
2)  Hodge DL, Yang J, Buschman MD, Schaughency PM, Dang H, Bere W, Yang Y, Savan R, Subleski JJ, Yin XM, Loughran TP, Young HA.
Interleukin-15 enhances proteasomal degradation of bid in normal lymphocytes: implications for large granular lymphocyte leukemias.
Cancer Res. 69: 3986-94, 2009.
[Journal]
3)  Whittaker GC, Burshtyn DN, Orr SJ, Quigley L, Hodge DL, Pascal V, Zhang W, McVicar DW.
Analysis of the linker for activation of T cells (LAT) and the linker for activation of B cells (LAB) in natural killer cells reveals a novel signaling cassette, dual usage in ITAM signaling, and influence on development of the Ly49 repertoire.
Blood. 2008.
[Journal]
4)  Berthet C, Rodriguez-Galan MC, Hodge DL, Gooya J, Pascal V, Young HA, Keller J, Bosselut R, Kaldis P.
Hematopoiesis and thymic apoptosis are not affected by the loss of Cdk2.
Mol. Cell. Biol. 27: 5079-89, 2007.
[Journal]
5)  Ortaldo JR, Winkler-Pickett R, Wigginton J, Horner M, Bere EW, Mason AT, Bhat N, Cherry J, Sanford M, Hodge DL, Young HA.
Regulation of ITAM-positive receptors: role of IL-12 and IL-18.
Blood. 107: 1468-75, 2006.
[Journal]
6)  Hodge DL, Subleski JJ, Reynolds DA, Buschman MD, Schill WB, Burkett MW, Malyguine AM, Young HA.
The proinflammatory cytokine interleukin-18 alters multiple signaling pathways to inhibit natural killer cell death.
J. Interferon Cytokine Res. 26: 706-18, 2006.
[Journal]
7)  Bream JH, Hodge DL, Gonsky R, Spolski R, Leonard WJ, Krebs S, Targan S, Morinobu A, O'Shea JJ, Young HA.
A distal region in the interferon-gamma gene is a site of epigenetic remodeling and transcriptional regulation by interleukin-2.
J. Biol. Chem. 279: 41249-57, 2004.
[Journal]
8)  Saleh A, Davies GE, Pascal V, Wright PW, Hodge DL, Cho EH, Lockett SJ, Abshari M, Anderson SK.
Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation.
Immunity. 21: 55-66, 2004.
[Journal]
9)  Salati LM, Szeszel-Fedorowicz W, Tao H, Gibson MA, Amir-Ahmady B, Stabile LP, Hodge DL.
Nutritional regulation of mRNA processing.
J. Nutr. 134: 2437S-2443S, 2004.
[Journal]
10)  Zhang X, Rodriguez-Galán MC, Subleski JJ, Ortaldo JR, Hodge DL, Wang JM, Shimozato O, Reynolds DA, Young HA.
Peroxisome proliferator-activated receptor-gamma and its ligands attenuate biologic functions of human natural killer cells.
Blood. 104: 3276-84, 2004.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 5/19/2011.